Navigation Links
InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
Date:11/6/2008

0, December 31,

2008 2007

Cash, cash equivalents and

available-for-sale

securities $185,561 $235,292

Other assets 20,219 27,153

Total assets $205,780 $262,445

Total other liabilities $34,202 $26,430

Liability under government

settlement 29,806 30,642

Deferred collaboration

revenue 63,807 66,261

Convertible senior notes 170,000 170,000

Stockholders' deficit (92,035) (30,888)

Total liabilities and

stockholders' deficit $205,780 $262,445


'/>"/>
SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ble in German . , Whether it,s CD packaging...adio Frequency Identification) are increasingly fi...ossible to label objects or goods and identify the...e scanner can read and process the data contained ... under production conditions of up to 100 degrees ...
(Date:11/24/2009)...Newswire-FirstCall/--IES(Nasdaq: IESC ),aleadingna...andservicesforthecommercial,industrialandresidenti...rouphasbeenawardedacontractfromManhattanTorconJVto...ab(BSL-4)replacementfacilityattheU.S.ArmyMedicalRe...tDetrickinFrederick,Md. ,, ThenewUSAMRIIDreplac...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...David Appia, French Ambassador for International I...rance Agency, , , , ,What: Ambassador Appia is av...usiness initiatives adopted by France to further d...e for innovation and development., , ,When: Availa...
(Date:11/24/2009)... The New York investment bank KTA Capital,s client...n AU$6.7 mil convertible note private placement wi...ement was arranged by KTA Capital as Neuren,s excl... New York (PRWEB) November 23, 2009 -- ...al, LLC ("KTA Capital") has announced th...
Breaking Biology Technology:Intelligence inside metal components 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
... The International,Confocal Microscopy Working Gro...and students, has been formed as a means to promot...onfocal microscopy (RCM) in,patient care., The Wo...dwide.,Dermatologists, dermascopists, dermatopatho...interested in learning more about RCM should consi...
...e Therapeutics,Inc. (OTC Bulletin Board: NILT.OB),... therapies for cardiovascular disease, is pleased ...., F.A.C.C. as its Vice President of,Clinical Rese...e. Dr. Lieu has extensive,cardiovascular clinical ...y,beneficial to Nile and our CD-NP and 2NTX-99 dev...
... Strativa,Pharmaceuticals, the proprietary product...rmaceutical Companies, Inc. (NYSE: PRX ) today,an...maceuticals, Inc.,(Amex: IMM ) has chosen to disc...aleate, an investigative therapy., On February 22...itional,reports of adverse events related to abnor...
Other Biology Technology:International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy 2Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 2Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 3Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 2Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 3
(Date:11/24/2009)...has been prescribed by traditional healers in Braz... stomach pain to fever and flu. , Now for the fir...been able to scientifically prove the pain relievi... as Brazilian mint. , Testing this ancient South ...Graciela Rocha was able to show that when prepared...
(Date:11/24/2009)...te (LRI) today named 12 new grant recipients for 2...innovative work across a broad spectrum of lupus r...ovelty, and potential to drive scientific discover...ex disease of systemic lupus. , The 2009 grants ...cross the nation and include interdisciplinary and...
(Date:11/24/2009)...new doors to understanding how sounds associated w...e mammal or if they hear it at all. , The same ... NASA uses to detect flaws in the space shuttle,s ...ists to peek inside the giant head of a whale. The...plicas of a whale,s hearing anatomy using a breakt...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Rocket science leads to new whale discovery 2New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 1New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 2Video 3A FDA Approves EMBEDA 28TM 29 For Management of Moderate to Severe Chronic Pain 54493 1Video 3A FDA Approves EMBEDA 28TM 29 For Management of Moderate to Severe Chronic Pain 54493 2Video 3A FDA Approves EMBEDA 28TM 29 For Management of Moderate to Severe Chronic Pain 54493 3Video 3A FDA Approves EMBEDA 28TM 29 For Management of Moderate to Severe Chronic Pain 54493 4Video 3A FDA Approves EMBEDA 28TM 29 For Management of Moderate to Severe Chronic Pain 54493 5Video 3A FDA Approves EMBEDA 28TM 29 For Management of Moderate to Severe Chronic Pain 54493 6Video 3A FDA Approves EMBEDA 28TM 29 For Management of Moderate to Severe Chronic Pain 54493 7Health Care Reform to be Discussed on Inside Government 54488 1Health Care Reform to be Discussed on Inside Government 54488 2
...A protein that causes coral to glow is helping res...edicine to light up brain cells that are critical ...system. This fluorescent marker protein may shed l... in various neurological diseases. The researchers...ember 20, 2006, issue of The Journal of Neuroscien...
...Mayo Clinic Cancer Center has opened a new Phase I...s against multiple myeloma, a cancer of the bone m...d of a series of molecular medicine studies in pat...cer. , “This is the beginning of a long but excit...logist and lead researcher on the multiple myeloma...
...Returning from a recent 1,000-mile expedition acro...ervation Society (WCS) biologist George Schaller r...t of rampant poaching -- may be increasing in numb... a growing conservation ethic in local communities... WCS and National Geographic, took place over a re...
Other Biology News:Researchers develop marker that identifies energy-producing centers in nerve cells 2Investigating the measles virus as a tool to kill multiple myeloma 2Investigating the measles virus as a tool to kill multiple myeloma 3Tibetan antelope slowly recovering, WCS says 2
Corning 96 Well Eia/Ria Microplate,Flat Bottom,Med Binding,Non-Sterile,W/O Lid from Sigma-Aldrich
...ss-to-seal gasket and cover slip enclosures which ...idizing and imaging thick or free floating specime...uild up to three chambers per slide. Minimize spec...ven when submerged. RNase-free, ready to use for m...
Secure-Seal hybridization chambers from Sigma-Aldrich
LC-NMR-MSn system from Bruker Daltonics
Biology Products: